Medicated Skincare Market, By Application (Cleanser, Serums, Lotions, Ointments, and Gels), By Skin Condition, By Product Features, By Distribution Channel, By Ingredient Type, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4671
|
Published Date
January 2026
|
Pages
380
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Medicated Skincare Market size was valued at US$ 78,090.10 Million in 2024, expanding at a CAGR of 4.35% from 2025 to 2032.
The Medicated Skincare Market comprises topical products clinically formulated to prevent, manage, or treat dermatological conditions such as acne, eczema, psoriasis, rosacea, and fungal or bacterial infections. Available as both prescription and over-the-counter options, these products bridge the gap between pharmaceuticals and cosmetics by combining therapeutic efficacy with everyday skincare benefits. Market growth is being driven by rising incidences of skin disorders linked to pollution, stress, and lifestyle changes, alongside increasing awareness among dermatologists and consumers. Skin conditions are a significant global health burden—affecting nearly 900million people worldwide at any given time and ranking among the most prevalent causes of illness globally, according to data compiled from global studies of dermatological disease prevalence.
A notable trend is the shift toward sciencebacked, gentle formulations featuring active dermatological ingredients such as ceramides, niacinamide, and salicylic acid. However, strict regulatory requirements and potential side effects from longterm use can pose challenges to adoption. At the same time, the growth of teledermatology services and ecommerce platforms presents significant opportunities, expanding global access to medicated skincare products and enabling more personalized treatment recommendations.
Medicated Skincare Market- Market Dynamics
Rising Dermatological Conditions and Growing Treatment Awareness
The growing prevalence of acne, dermatitis, hyperpigmentation, and rosacea is driving demand for medicated skincare products. Consumers are increasingly seeking clinically validated solutions over cosmetic alternatives, boosting the popularity of prescription-grade cleansers, serums, and moisturizers. Dermatologists play a crucial role in recommending targeted treatments that address inflammation, bacterial growth, and skin barrier repair. Enhanced product visibility is further supported by social awareness campaigns, digital dermatology platforms, and easy access to online consultations. Factors such as pollution, hormonal imbalances, and lifestyle-related stress further emphasize the need for daily medicated skincare routines. This shift toward science-backed ingredients supports long-term category growth. For instance, VisualDx, a digital diagnostic tool used by dermatologists, includes over 45,000 medical images that aid clinicians in remote consultations, improving the accuracy of diagnosing hyperpigmentation, rosacea, and other skin disorders.
Medicated Skincare Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Application, Skin Condition, Product Features, Distribution Channel, Ingredient Type, and Region.
In 2025, acne treatment remained the leading skin care segment, accounting for nearly 42% of the market, driven by rising cases of hormonal acne, pollution-related skin issues, and the widespread use of salicylic acid, benzoyl peroxide, and retinoid-based products. Dermatologists continued to recommend medicated solutions over cosmetic alternatives, reinforcing consumer confidence in these treatments. Anti-aging products also gained traction due to strong demand for peptides and retinoids, while sensitive skin formulations expanded as more consumers sought hypoallergenic and fragrance-free options. For example, Galderma reported positive Phase III trial results for a gel containing 0.3% adapalene and 2.5% benzoyl peroxide. In the study, 503 patients with moderate-to-severe acne treated over 12 weeks experienced mean reductions of 27 inflammatory lesions (-68.7%) and 40 non-inflammatory lesions (-68.3%), compared to lower efficacy in the vehicle group.
By application, the cleanser segment remains the most popular in the medicated skincare market, driven by high demand for dermatologically tested face washes, antibacterial formulations, and pH-balanced solutions. Cleansers are often the first step in treating acne, controlling excess oil, and removing impurities, and growth is supported by increased awareness of multi-step routines and doctor recommendations for medicated cleansing agents. Serums and moisturizers have also seen steady growth as brands introduce targeted formulations to address pigmentation, dryness, and post-treatment recovery. For instance, La Roche-Posay’s Effaclar Purifying Foaming Gel maintains a physiological pH of 5.5 to support the skin’s natural balance and contains zinc PCA, which manufacturer studies indicate reduces sebum production. Tested by dermatologists, the product is described as a non-irritating cleanser suitable for sensitive and acne-prone skin.
Medicated Skincare Market- Geographical Insights
North America represents a significant market for medicated skincare products, driven by advances in medical science and technology that have improved product efficacy while minimizing side effects. Consumer awareness of skin health and available treatments is high, further boosting demand for therapeutic skincare solutions. Additionally, the widespread adoption of fast-food diets contributes to the prevalence of skin issues in the region. Many fast-food items—such as burgers, hot dogs, french fries, nuggets, milkshakes, and sodas—are high in refined carbohydrates, fats, and calories, which can trigger allergic reactions and various dermatological problems. According to Safety and Health Magazine (December 2018), approximately 37% of the American population consumes fast food daily, highlighting the potential need for skincare interventions.
United States Medicated Skincare Market- Country Insights
The United States holds a significant share of the medicated skincare market, driven by strong demand for clinically validated treatments for acne, eczema, and other inflammatory skin conditions. This growth is supported by high healthcare spending and broad access to dermatologists. Both prescription and over-the-counter therapeutic skincare segments are expanding, fueled by innovation and regulatory approvals. For example, in August 2024, the FDA approved Galderma’s Nemluvio® (nemolizumab) for moderate-to-severe atopic dermatitis, providing new options for chronic inflammatory skin conditions. In July 2025, CeraVe introduced five new therapeutic products, including baby eczema relief and blemish barrier solutions, addressing consumer demand for dermatologist-recommended formulas. Additionally, expanded pediatric approval for Incyte’s Opzelura in 2025 reflects a growing focus on age-inclusive dermatological treatments. These developments highlight how innovation, regulatory support, and robust clinical pipelines are strengthening the U.S. medicated skincare market.
Medicated Skincare Market- Competitive Landscape:
The medicated skincare market is highly competitive, with numerous global and regional players striving to capture market share. Leading companies are prioritizing product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market positions. Research and development is central to this effort, as companies seek to introduce advanced formulations that deliver superior efficacy and address diverse consumer needs. Additionally, the growing emphasis on clean and sustainable beauty is shaping strategies, with a focus on eco-friendly ingredients and sustainable packaging to meet increasing consumer demand. Major multinational corporations, including Johnson & Johnson, Procter & Gamble, L’Oréal, and Unilever, dominate the market due to their extensive product portfolios, global reach, and well-established distribution networks. These companies leverage brand equity, marketing, and promotional activities to maintain competitive advantage and enhance consumer engagement.
Recent Developments:
- In May 2024, Otsuka Pharmaceutical Co., Ltd. launched InnerSignal, a basic skincare line featuring “Repair Lotion” and “Repair Milk” designed to address epidermal imbalance and promote cellular turnover. The products combine high-moisturizing ingredients with active medicinal components like dipotassium glycyrrhizate and ectoin to help prevent rough skin and dullness caused by dryness and UV exposure.
- In June 2024, SkinCeuticals introduced P-TIOX, a clinically proven peptide serum aimed at reducing the appearance of expression lines and wrinkles. The serum combines peptides and antioxidants to improve skin smoothness and firmness and is available through SkinCeuticals’ official channels.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICATED SKINCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- L’Oréal S.A.
- Beiersdorf AG
- Mary Kay Inc.
- Oriflame Holding AG
- BASF SE
- Galderma Laboratories
- Johnson & Johnson
- Procter & Gamble Co.
- Unilever Plc.
- Neocutis
- SkinCeuticals
- Obagi Medical
- Dermalogica
- La Roche-Posay
- Murad
- PCA Skin
- Others
GLOBAL MEDICATED SKINCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cleanser
- Serums
- Lotions
- Ointments
- Gels
GLOBAL MEDICATED SKINCARE MARKET, BY SKIN CONDITION- MARKET ANALYSIS, 2019 - 2032
- Acne
- Rosacea
- Eczema
- Psoriasis
- Hyperpigmentation
GLOBAL MEDICATED SKINCARE MARKET, BY PRODUCT FEATURES- MARKET ANALYSIS, 2019 - 2032
- Hypoallergenic
- Paraben-free
- Non-comedogenic
- Fragrance-free
- Cruelty-free
GLOBAL MEDICATED SKINCARE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Prescription
- Online retail
- Over-the-counter
- Pharmacies
- Dermatologist clinics
GLOBAL MEDICATED SKINCARE MARKET, BY INGREDIENT TYPE- MARKET ANALYSIS, 2019 - 2032
- Antioxidants
- Moisturizers
- Anti-inflammatories
- Antibacterials
- Antifungals
GLOBAL MEDICATED SKINCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Medicated Skincare Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Medicated Skincare Market Snippet by Application
2.1.2. Medicated Skincare Market Snippet by Skin Condition
2.1.3. Medicated Skincare Market Snippet by Product Features
2.1.4. Medicated Skincare Market Snippet by Distribution Channel
2.1.5. Medicated Skincare Market Snippet by Ingredient Type
2.1.6. Medicated Skincare Market Snippet by Country
2.1.7. Medicated Skincare Market Snippet by Region
2.2. Competitive Insights
3. Medicated Skincare Key Market Trends
3.1. Medicated Skincare Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Medicated Skincare Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Medicated Skincare Market Opportunities
3.4. Medicated Skincare Market Future Trends
4. Medicated Skincare Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Medicated Skincare Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Medicated Skincare Market Landscape
6.1. Medicated Skincare Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Medicated Skincare Market – By Application
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
7.1.2. Cleanser
7.1.3. Serums
7.1.4. Lotions
7.1.5. Ointments
7.1.6. Gels
8. Medicated Skincare Market – By Skin Condition
8.1. Overview
8.1.1. Segment Share Analysis, By Skin Condition, 2024 & 2032 (%)
8.1.2. Acne
8.1.3. Rosacea
8.1.4. Eczema
8.1.5. Psoriasis
8.1.6. Hyperpigmentation
9. Medicated Skincare Market – By Product Features
9.1. Overview
9.1.1. Segment Share Analysis, By Product Features, 2024 & 2032 (%)
9.1.2. Hypoallergenic
9.1.3. Paraben-free
9.1.4. Non-comedogenic
9.1.5. Fragrance-free
9.1.6. Cruelty-free
10. Medicated Skincare Market – By Distribution Channel
10.1. Overview
10.1.1. Segment Share Analysis, By Skin Condition, 2024 & 2032 (%)
10.1.2. Prescription
10.1.3. Online retail
10.1.4. Over-the-counter
10.1.5. Pharmacies
10.1.6. Dermatologist clinics
11. Medicated Skincare Market – By Ingredient Type
11.1. Overview
11.1.1. Segment Share Analysis, By Ingredient Type, 2024 & 2032 (%)
11.1.2. Antioxidants
11.1.3. Moisturizers
11.1.4. Anti-inflammatories
11.1.5. Antibacterials
11.1.6. Antifungals
12. Medicated Skincare Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Medicated Skincare Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Medicated Skincare Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Medicated Skincare Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Medicated Skincare Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Medicated Skincare Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Skin Condition, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Product Features, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Ingredient Type, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Medicated Skincare Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. L’Oréal S.A.
13.2.2. Beiersdorf AG
13.2.3. Mary Kay Inc.
13.2.4. Oriflame Holding AG
13.2.5. BASF SE
13.2.6. Galderma Laboratories
13.2.7. Johnson & Johnson
13.2.8. Procter & Gamble Co.
13.2.9. Unilever Plc.
13.2.10. Neocutis
13.2.11. SkinCeuticals
13.2.12. Obagi Medical
13.2.13. Dermalogica
13.2.14. La Roche-Posay
13.2.15. Murad
13.2.16. PCA Skin
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICATED SKINCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- L’Oréal S.A.
- Beiersdorf AG
- Mary Kay Inc.
- Oriflame Holding AG
- BASF SE
- Galderma Laboratories
- Johnson & Johnson
- Procter & Gamble Co.
- Unilever Plc.
- Neocutis
- SkinCeuticals
- Obagi Medical
- Dermalogica
- La Roche-Posay
- Murad
- PCA Skin
- Others
GLOBAL MEDICATED SKINCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cleanser
- Serums
- Lotions
- Ointments
- Gels
GLOBAL MEDICATED SKINCARE MARKET, BY SKIN CONDITION- MARKET ANALYSIS, 2019 - 2032
- Acne
- Rosacea
- Eczema
- Psoriasis
- Hyperpigmentation
GLOBAL MEDICATED SKINCARE MARKET, BY PRODUCT FEATURES- MARKET ANALYSIS, 2019 - 2032
- Hypoallergenic
- Paraben-free
- Non-comedogenic
- Fragrance-free
- Cruelty-free
GLOBAL MEDICATED SKINCARE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Prescription
- Online retail
- Over-the-counter
- Pharmacies
- Dermatologist clinics
GLOBAL MEDICATED SKINCARE MARKET, BY INGREDIENT TYPE- MARKET ANALYSIS, 2019 - 2032
- Antioxidants
- Moisturizers
- Anti-inflammatories
- Antibacterials
- Antifungals
GLOBAL MEDICATED SKINCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
